2012 Platform and Poster Presentations Abstracts

Abstracts of the 2012 platform, poster and invited presentations may be viewed online by clicking here. Onsite, Abstracts will be made available for online viewing and print on demand only to reduce unnecessary printing and will be accessed at the Search and Printing Stations located in C Concourse of the Charlotte Convention Center or via smartphone and tablet platforms.

Call for Abstracts

The presentation of cutting-edge research is an essential feature of the ACMG Annual Clinical Genetics Meeting, and genetics professionals (ACMG members and non-members) are encouraged to submit abstracts for presentation. Submitted abstracts may be selected for poster displays or platform presentations.  Abstracts will be published online and distributed in electronic and print format to the ACMG Annual Meeting attendees. 

Abstract Selection Procedure

The Program Committee will select the highest scoring abstracts for either oral or poster communication and designate them to the appropriate session. Submitters will be notified of acceptance or rejection, and format of presentation (Oral Platform or Poster) by mid-January 2012.  

NOTE:  Acceptance as an oral or poster presenter for the 2012 ACMG Annual Clinical Genetics meeting does not cover the cost of travel to the meeting, registration for the conference, or printing of poster materials.   Please note that by submitting an abstract, the submitter agrees to attend the meeting and present the poster or take part in the oral presentations. 

Confirmation of submission, acceptance and/or rejection will be communicated via email. To assure receipt of all communication regarding abstract submission – please have your IT Department set your institutions’ server (or set your email filter, spam blocker or server directly) to accept, and not block emails from: acmg@mirasmart.com.

Abstract topics include:
Biochemical Genetics
Perinatal Genetics
Clinical Genetics
Genetic Counseling
Cytogenetics
Education/Public Health/Legal & Ethical Issues
Molecular Genetics

Detailed submission guidelines are outlined below.  Submitted abstracts may be selected for poster displays or platform presentations.  Abstracts will be published online and distributed on site via electronic and print media.

Poster session will highlight original scientific research and will be accessible during all hours that exhibits are open, with presenters at their boards for one hour on Thursday, March 29, 2012 and Friday, March 30, 2012.  The poster display area will be 3’8” x 3’8”.

Platform presentations highlight original scientific research and will be presented as 10-minute talk, 5-minute Q&A in concurrent sessions on Thursday, March 29, 2012 and Friday, March 30, 2012. 

Signature Genomics will once again sponsor a travel award for the first author of a selected platform presentation to attend the 2012 annual meeting. Some restrictions apply. Interested individuals can apply for the award during the abstract submission process.

Abstract Submission Guidelines and Instructions

Abstracts must be submitted in English only. The material for presentation should be unpublished and original.  Encore presentations are allowed, only if material was previously presented at a non-genetics meeting. 

Abstracts are limited to 3,200 characters, including title, authors, affiliations, spaces, abstract and footnotes. 

There is no limit on the number of abstracts an individual may submit; however an individual may be first author on only one abstract.  Abstracts should be submitted with the intention that they will be presented if selected.  Do not submit an abstract if you will not attend the meeting.  Authors who do not present as scheduled and do not notify ACMG, in advance, of a need to cancel, may not be invited to present at future meetings. 

Disclosure:  In accordance with the Accreditation Council for Continuing Medical Education and the policy of the American College of Medical Genetics, before their presentations, all Oral Abstract submitters must disclose the existence of any financial interest and/or other relationship(s) they might have with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) to be discussed during their presentation.  Any Oral Abstract presenter with a Financial Disclosure/Conflict of Interest will be contacted by the Program Committee for a slide review and must include a disclosure slide at the start of their presenation. The full text of the disclosure will appear on the website as part of the submission process. All submitters must complete this disclosure statement.  Disclosures will be included in the on-site Program Guide.  CME will not be offered for Poster Presentations.

ACMG supports medical information privacy.  While the ACMG is not a “covered entity” under HIPAA 1996 and therefore is not required to meet these standards, ACMG wishes to take reasonable steps to ensure that the presentation of individually identifiable health information at ACMG-sponsored events has been properly authorized.  Every presenter must agree to one of the statements on the “Verification of HIPAA Authorization” to be found on the web submission site.  Abstracts cannot be submitted without this verification of compliance.

Abstract presenters must register for full to attend the meeting.  Registration opens in October 2011.